Home/Filings/4/0001415889-24-015976
4//SEC Filing

Burstein Jennifer 4

Accession 0001415889-24-015976

CIK 0001623526other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 4:29 PM ET

Size

12.6 KB

Accession

0001415889-24-015976

Insider Transaction Report

Form 4
Period: 2024-06-05
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2024-06-05+7,6397,639 total
    Exercise: $16.41Exp: 2034-06-04Common Stock (7,639 underlying)
Footnotes (1)
  • [F1]The option shall vest in full on the earlier of: (i) June 5, 2025 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date.

Issuer

Stoke Therapeutics, Inc.

CIK 0001623526

Entity typeother

Related Parties

1
  • filerCIK 0001640069

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:29 PM ET
Size
12.6 KB